Klaudia Kuranda et al.
Molecular therapy. Methods & clinical development, 13, 112-120 (2019-02-12)
Hematopoietic stem cell transplantation (HSCT) using unrelated cord blood (CB) donors is a suitable approach when an HLA-matched donor is not available. However, one important drawback is the risk of life-threatening viral infections prior to immune reconstitution, particularly from adenoviruses (AdVs).